RUARua Life Sciences Plc
26.00GBP0.00%Mkt Cap: 20.70M $P/E: Infinity

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufactu…

Key Statistics

Company
Market Cap20.70M $
Enterprise Value18.55M $
Revenue (TTM)5.92M $
Gross Profit2.28M $
Net Income (TTM)-1.85M $
Revenue/Share0.0949 USD
Last Price26.00 GBP
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees59
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)Infinity
P/E (Forward)-65.00
PEG
EV/EBITDA25.15
EV/Revenue3.13
P/S3.49
P/B2.30
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
10.4284% of range28.90
52W High28.90 GBP
52W Low10.42 GBP
Profitability
Gross Margin81.06%
Oper. Margin-8.52%
EBITDA Margin12.45%
Profit Margin-65.72%
ROE-20.05%
ROA-17.63%
Growth
Revenue Growth6.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-1.70M $
CapEx (TTM)70.54K $
FCF Margin
FCF Yield
Net Debt-2.20M $
Net Debt/EBITDA-2.98
Balance Sheet
Debt/Equity0.05
Current Ratio5.92
Quick Ratio4.44
Book Value/Sh0.1130 GBP
Cash/Share0.0380 GBP
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 GBP
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateSep 1, 2003
Analyst Consensus
Rating
Target (Mean)50.00 GBP
Upside (mean)+92.3%
Target Range50.00 GBP50.00 GBP
# Analysts1
Ownership
Shares Out.62.06M
Float50.42M
Insiders19.16%
Institutions17.58%
Technical
SMA 5022.41 (+16.0%)
SMA 20017.02 (+52.7%)
Beta0.97
S&P 52W Chg18.16%
Avg Vol (30d)164.92K
Avg Vol (10d)142.07K
Technical Indicators
RSI (14)62.3
MACD0.9775
MACD Signal0.9510
MACD Hist.+0.0265
BB Upper27.02 GBP
BB Middle24.79 GBP
BB Lower22.56 GBP
BB Width18.00%
ATR (14)1.440 GBP
Vol Ratio (20d)1.00x